tiprankstipranks
Trending News
More News >

Douglas Ingram Insider Profile

18 Followers
Douglas Ingram, President at Allergan, holds 46.22K shares in Arrowhead Pharmaceuticals (Ticker: ARWR), holds 929.39K shares in Sarepta Therapeutics (Ticker: SRPT), holds 25.00K shares in Relay Therapeutics (Ticker: RLAY).
tipranks
Douglas Ingram

Douglas Ingram
Allergan (AGN)
President

Ranked #5,019 out of 106,131 Corporate Insiders

Profitable Transactions

63%
5 out of 8 Profitable Transactions

Average Return

+47.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$18M
82.50%
16.17%
1.33%
A breakdown of Douglas Ingram's holdings

Insider Roles

Sarepta Therapeutics
(SRPT)
CEO, Director
Arrowhead Pharmaceuticals
(ARWR)
Director
Relay Therapeutics
(RLAY)
Director
Roles that Douglas Ingram holds in companies

Most Profitable Insider Trade

Stock:
Sarepta Therapeutics
(SRPT)
Rating:Informative Buy
Date:Jul 28, 2017 - Jul 28, 2018
Return:+191.90%
The most profitable trade made by Douglas Ingram

Douglas Ingram's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AGN
Allergan
Mar 19, 2015
Uninformative Buy
$0.00
ENDPQ
Endo International
Jun 12, 2017
Uninformative Buy
$0.00
Sarepta Therapeutics
Dec 09, 2025
CEO, Director
Uninformative Buy
$15.17M
Relay Therapeutics
Jul 21, 2020
Director
Informative Buy
500.00K
$244.75K
Arrowhead Pharmaceuticals
Dec 18, 2025
Director
Uninformative Buy
$2.97M
List of latest transactions for each holding click on a transaction to see Douglas Ingram's performance on stock

Douglas Ingram insider profile FAQ

What is the percentage of profitable transactions made by Douglas Ingram?
The percentage of profitable transactions made by Douglas Ingram is 63%.
    What is the average return per transaction made by Douglas Ingram?
    The average return per transaction made by Douglas Ingram is 47.30%.
      What stocks does Douglas Ingram hold?
      Douglas Ingram holds: AGN, ENDPQ, SRPT, RLAY, ARWR stocks.
        What was Douglas Ingram’s latest transaction?
        Douglas Ingram latest transaction was an Uninformative Buy of ―.
          What was Douglas Ingram's most profitable transaction?
          Douglas Ingram’s most profitable transaction was an Informative Buy of SRPT stock on July 28, 2017. The return on the trade was 191.90%.
            What is Douglas Ingram's role in Allergan?
            Douglas Ingram's role in Allergan is President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.